Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review-Reference-Cited by-同舟云学术

Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review

Published:2023-02 Issue:1 Volume:6 Page:16-27
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

de Barros Hilda A.,van Beurden Isabeau,Droghetti Matteo,Wilthagen Erica A.,Özman Oktay,Bergman Andries M.,Aluwini Shafak,van Moorselaar R. Jeroen A.,Donswijk Maarten L.,van Leeuwen Pim J.,van der Poel Henk G.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference48 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021

2. Enzalutamide with standard first-line therapy in metastatic prostate cancer;Davis;N Engl J Med,2019

3. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

4. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017

5. NCCN. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer (version 1.2023), Volume 8. 2022. p. 938–44.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol for Evaluating the Efficacy and Safety of Radiotherapy for Prostate and Oligometastatic Lesions in Patients With Low-Burden Sensitive Oligometastatic Prostate Cancer: An Open, Exploratory Pilot Clinical Trial;Cancer Control;2024-01

2. Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer;Minerva Urology and Nephrology;2023-12

3. 68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-08-14

4. Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer;EJNMMI Research;2023-07-06

5. Cervical lymphadenopathy as initial presentation of metastatic prostate cancer: A retrospective study of five cases and literature review;Frontiers in Surgery;2023-01-30